$334 Million is the total value of Integral Health Asset Management, LLC's 60 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PFNX | Exit | PFENEX INC | $0 | – | -85,000 | -100.0% | -0.33% | – |
| Exit | AMARIN CORP PLC | $0 | – | -200,000 | -100.0% | -0.35% | – | |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.56% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -250,000 | -100.0% | -0.66% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -40,000 | -100.0% | -0.71% | – |
| Exit | EXELIXIS INC | $0 | – | -100,000 | -100.0% | -0.76% | – | |
| ALKS | Exit | ALKERMES PLC | $0 | – | -150,000 | -100.0% | -0.95% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -40,000 | -100.0% | -1.10% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -10,000 | -100.0% | -1.10% | – |
| NVO | Exit | NOVO-NORDISK A Sadr | $0 | – | -55,000 | -100.0% | -1.46% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -7,000 | -100.0% | -1.53% | – |
| CHWY | Exit | CHEWY INCcl a | $0 | – | -100,000 | -100.0% | -1.65% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -100,000 | -100.0% | -1.71% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -125,000 | -100.0% | -1.80% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -25,000 | -100.0% | -2.53% | – |
| NVS | Exit | NOVARTIS A Gsponsored adr | $0 | – | -70,000 | -100.0% | -2.54% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -35,000 | -100.0% | -2.73% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -115,000 | -100.0% | -3.24% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -170,000 | -100.0% | -4.45% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -115,000 | -100.0% | -4.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.